-
Je něco špatně v tomto záznamu ?
The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's disease
O. Hradsky, P. Dusatkova, M. Lenicek, J. Bronsky, J. Nevoral, L. Vitek, M. Lukas, I. Zeniskova, O. Cinek,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
BioMedCentral
od 2000-12-01 do 2020-12-31
BioMedCentral Open Access
od 2000
Directory of Open Access Journals
od 2000
Free Medical Journals
od 2000
PubMed Central
od 2000 do 2020
Europe PubMed Central
od 2000
ProQuest Central
od 2009-01-01 do 2021-01-31
Open Access Digital Library
od 2000-11-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2000-01-01
Medline Complete (EBSCOhost)
od 2000-01-01 do 2021-03-12
Health & Medicine (ProQuest)
od 2009-01-01 do 2021-01-31
ROAD: Directory of Open Access Scholarly Resources
od 2000
Springer Nature OA/Free Journals
od 2000-12-01 do 2020-12-31
PubMed
20537165
DOI
10.1186/1471-2350-11-91
Knihovny.cz E-zdroje
- MeSH
- alely MeSH
- antigen CTLA-4 MeSH
- běloši genetika MeSH
- CD antigeny MeSH
- Crohnova nemoc epidemiologie genetika MeSH
- cytotoxické T-lymfocyty MeSH
- genotyp MeSH
- haplotypy MeSH
- idiopatické střevní záněty genetika MeSH
- jednonukleotidový polymorfismus MeSH
- lidé MeSH
- polymorfismus genetický MeSH
- rizikové faktory MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: The CTLA4 (cytotoxic T-lymphocyte antigen 4) gene is associated with several immunopathologic diseases and because of its important immuno-regulatory role it may be considered also a plausible candidate for a genetic association with inflammatory bowel diseases. Previously published studies found no association of CTLA4 with Crohn's disease itself, but some indicated an association with its subphenotypes. The aim of this study was to assess the association in the Czech population, using a set of markers shown to associate with other diseases. METHODS: Six polymorphisms within the CTLA4 region were investigated in 333 patients with Crohn's disease and 482 unrelated healthy controls, all Caucasians of Czech origin. The genotypes of the SNPs were determined using the TaqMan SNP genotyping assays. Haplotypes were reconstructed using an expectation-maximization algorithm, and their association with the condition was assessed using log-linear modeling. Then, potential interactions were tested between the CTLA4 variants and other genetic factors known to confer the disease susceptibility. RESULTS: No crude associations with Crohn's disease were found for the tested CTLA4 variants under the log-additive or dominant models. However, when stratified for the genetic risk conferred by the variants in the NOD2 (the p.Leu1007fsX1008, rs5743293) or the IL23R (p.R381Q, rs11209026), a significant negative association emerged for the minor alleles of CTLA4 CT60 (rs3087243), JO31 (rs11571302), JO27-1 (rs11571297) polymorphisms. This negative association with CTLA4 was apparent only in the strata defined by presence minor alleles at the NOD2 rs5743293 (here the CTLA4 CT60 A coffered an OR = 0.43, 95%CI 0.19 - 0.95 for the presence of CT60 A), or IL23R rs11209026 (here the OR for presence of CT60 A was 0.23, 95%CI 0.07 - 0.71). We observed this effect also for the haplotype consisting of minor alleles of the three tightly linked CTLA4 markers. Furthermore, this haplotype was associated with the younger age at diagnosis (OR 1.52, 95%CI 1.09 - 2.11, p = 0.014). CONCLUSIONS: A protective effect of a CTLA4 haplotype was unmasked after stratification for the risk variants in the NOD2 and IL23R genes, and may point towards the biological relevance of the molecule in the pathogenesis of the disease.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025653
- 003
- CZ-PrNML
- 005
- 20121206121610.0
- 007
- ta
- 008
- 120817e20100610enk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1186/1471-2350-11-91 $2 doi
- 035 __
- $a (PubMed)20537165
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Hradsky, Ondrej $u Department of Pediatrics, University Hospital Motol and Second Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. ondrej.hradsky@lfmotol.cuni.cz
- 245 14
- $a The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's disease / $c O. Hradsky, P. Dusatkova, M. Lenicek, J. Bronsky, J. Nevoral, L. Vitek, M. Lukas, I. Zeniskova, O. Cinek,
- 520 9_
- $a BACKGROUND: The CTLA4 (cytotoxic T-lymphocyte antigen 4) gene is associated with several immunopathologic diseases and because of its important immuno-regulatory role it may be considered also a plausible candidate for a genetic association with inflammatory bowel diseases. Previously published studies found no association of CTLA4 with Crohn's disease itself, but some indicated an association with its subphenotypes. The aim of this study was to assess the association in the Czech population, using a set of markers shown to associate with other diseases. METHODS: Six polymorphisms within the CTLA4 region were investigated in 333 patients with Crohn's disease and 482 unrelated healthy controls, all Caucasians of Czech origin. The genotypes of the SNPs were determined using the TaqMan SNP genotyping assays. Haplotypes were reconstructed using an expectation-maximization algorithm, and their association with the condition was assessed using log-linear modeling. Then, potential interactions were tested between the CTLA4 variants and other genetic factors known to confer the disease susceptibility. RESULTS: No crude associations with Crohn's disease were found for the tested CTLA4 variants under the log-additive or dominant models. However, when stratified for the genetic risk conferred by the variants in the NOD2 (the p.Leu1007fsX1008, rs5743293) or the IL23R (p.R381Q, rs11209026), a significant negative association emerged for the minor alleles of CTLA4 CT60 (rs3087243), JO31 (rs11571302), JO27-1 (rs11571297) polymorphisms. This negative association with CTLA4 was apparent only in the strata defined by presence minor alleles at the NOD2 rs5743293 (here the CTLA4 CT60 A coffered an OR = 0.43, 95%CI 0.19 - 0.95 for the presence of CT60 A), or IL23R rs11209026 (here the OR for presence of CT60 A was 0.23, 95%CI 0.07 - 0.71). We observed this effect also for the haplotype consisting of minor alleles of the three tightly linked CTLA4 markers. Furthermore, this haplotype was associated with the younger age at diagnosis (OR 1.52, 95%CI 1.09 - 2.11, p = 0.014). CONCLUSIONS: A protective effect of a CTLA4 haplotype was unmasked after stratification for the risk variants in the NOD2 and IL23R genes, and may point towards the biological relevance of the molecule in the pathogenesis of the disease.
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a CD antigeny $7 D015703
- 650 _2
- $a antigen CTLA-4 $7 D060908
- 650 _2
- $a Crohnova nemoc $x epidemiologie $x genetika $7 D003424
- 650 _2
- $a běloši $x genetika $7 D044465
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a haplotypy $7 D006239
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a idiopatické střevní záněty $x genetika $7 D015212
- 650 _2
- $a polymorfismus genetický $7 D011110
- 650 _2
- $a jednonukleotidový polymorfismus $7 D020641
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a cytotoxické T-lymfocyty $7 D013602
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Dusatkova, Petra
- 700 1_
- $a Lenicek, Martin
- 700 1_
- $a Bronsky, Jiri
- 700 1_
- $a Nevoral, Jiri
- 700 1_
- $a Vitek, Libor
- 700 1_
- $a Lukas, Milan
- 700 1_
- $a Zeniskova, Ivana
- 700 1_
- $a Cinek, Ondrej
- 773 0_
- $w MED00008188 $t BMC medical genetics $x 1471-2350 $g Roč. 11(20100610), s. 91
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20537165 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121206121643 $b ABA008
- 999 __
- $a ok $b bmc $g 947695 $s 782999
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 11 $d 91 $e 20100610 $i 1471-2350 $m Bmc medical genetics $n BMC Med Genet $x MED00008188
- LZP __
- $a Pubmed-20120817/10/03